<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03666299</url>
  </required_header>
  <id_info>
    <org_study_id>GZFPH-2018-114</org_study_id>
    <nct_id>NCT03666299</nct_id>
  </id_info>
  <brief_title>Lidocaine Infusion for Postthoracotomy Pain Syndrome</brief_title>
  <acronym>LIPPS</acronym>
  <official_title>Lidocaine Infusion for Postthoracotomy Pain Syndrome, A Prospective, Randomized, Double-blind, Placebo-controlled Trial (LIPPS Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou First People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou First People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to investigate lidocaine infusion to reduce postthoractomy pain syndrome
      after thoracic Surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postthoracotomy pain syndrome (PPS) is defined as a persistent and/or recurrent pain or
      burning sensation along the thoracotomy scar at 3 months after surgery. The pain is very
      significant, given that 3 to 5% of postthoractomy patients report it as being severe, and
      approximately 50% of patients report limitations in their activities of daily living. Little
      is known about the origin of this pain, but it seems that the intensity of acute
      postoperative pain is the best predictor of it. Lidocaine infusion could be a possible
      approach to reducing the prevalence of PPS. Recently, a meta-analysis concluded a modest but
      statistically significant reduction of pain severity in the first four postoperative hours
      measured by the visual analogue scale (mean difference, -0.84; 95% CI, -1.10 to -0.59).
      However, a more recent meta-analysis found that only limited clinical data and biological
      plausibility support lidocaine infusions for the prevention of postoperative persistent pain
      (odds ratio, 0.29; 95% CI, 0.18 to 0.48). This study was designed to investigate whether
      lidocaine infusion after video-assisted thoracoscopic surgery (VATS) would lower PPS at
      postoperative 3 and 6 month.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 6, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of chronic pain</measure>
    <time_frame>At 3 months after surgery.</time_frame>
    <description>Chronic pain was assessed in accordance with the IMMPACT recommends in the domains of: (1) absence or presence of pain in the area of the surgery, (2) clinically important (NRS ≥ 4 on a 0- to 10-point scale) daily average pain, (3) clinically important pain at rest, (4) clinically important pain intensity upon movement or activity, (5) pain qualities, and (6) physical and emotional functioning.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative acute pain</measure>
    <time_frame>postoperative days 1 and 2.</time_frame>
    <description>Use numeric rating scale (NRS) to assess the postoperative acute pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>postoperative days 1 and 2.</time_frame>
    <description>Use numeric rating scale (NRS) to asses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting (PONV) nausea</measure>
    <time_frame>postoperative days 1 and 2.</time_frame>
    <description>Use numeric rating scale (NRS) to assess</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>postoperative days 1 and 2.</time_frame>
    <description>Use numeric rating scale (NRS) to assess</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of chronic pain at 6-month</measure>
    <time_frame>At 6 months after surgery.</time_frame>
    <description>Chronic pain was assessed in accordance with the IMMPACT recommends in the domains of: (1) absence or presence of pain in the area of the surgery, (2) clinically important (NRS ≥ 4 on a 0- to 10-point scale) daily average pain, (3) clinically important pain at rest, (4) clinically important pain intensity upon movement or activity, (5) pain qualities, and (6) physical and emotional functioning.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Postthoracotomy ipsilateral shoulder pain</measure>
    <time_frame>postoperative days 1 and 2.</time_frame>
    <description>Use numeric rating scale (NRS) to assess</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Thoracic Surgery, Video-Assisted</condition>
  <condition>Lidocaine</condition>
  <condition>Pain, Postoperative</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lidocaine treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Infusion of 2% lidocaine hydrochloride at 4 mL/h, started after tracheal intubation and discontinued until 24 h after surgery.</description>
    <arm_group_label>Lidocaine</arm_group_label>
    <other_name>intravenous lidocaine infusion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Infusion of normal saline at 4 mL/h, started after tracheal intubation and discontinued until 24 h after surgery.</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>normal saline control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled to undergo a muscle-sparing lateral minithoracotomy for different
             thoracic diseases

        Exclusion Criteria:

          -  (1)ASA classification status III or above

          -  (2)Body weight＜35kg

          -  (3)Liver cirrhosis

          -  (4)A history of previous thoracotomy

          -  (5)Pregnancy

          -  (6)Severe arrhythmia

          -  (7)Congestive heart failure

          -  (8)Opioid or steroid use 6 months before surgery

          -  (9)Allergy to lidocaine

          -  (10)Chronic pain syndrome (any type)

          -  (11)Emergency surgery

          -  (12)Incapacity to give an informed consent, Visual dysfunction or severe mental
             disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiangcai Ruan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Affliated First People's Hospital of Guangzhou ,Guangzhou Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiangcai Ruan, PhD</last_name>
    <phone>+8620-81048306</phone>
    <email>xc_ruan@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Danyang Pan, MD</last_name>
    <phone>+86-13246886285</phone>
    <email>Pandy0505@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guangzhou First People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510180</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Luo, MD</last_name>
      <phone>020-81045412</phone>
      <email>MEC_GZSY@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Wang JL, Zhang WJ, Gao M, Zhang S, Tian DH, Chen J. A cross-cultural adaptation and validation of the short-form McGill Pain Questionnaire-2: Chinese version in patients with chronic visceral pain. J Pain Res. 2017 Jan 5;10:121-128. doi: 10.2147/JPR.S116997. eCollection 2017.</citation>
    <PMID>28115872</PMID>
  </reference>
  <reference>
    <citation>Slovack M, Taylor B, Bryce R, Ong D. Does intravenous lidocaine infusion during video-assisted thoracoscopic surgery reduce postoperative analgesia? A randomized controlled study. Can J Anaesth. 2015 Jun;62(6):676-7. doi: 10.1007/s12630-015-0333-z. Epub 2015 Feb 11.</citation>
    <PMID>25670347</PMID>
  </reference>
  <reference>
    <citation>Brulotte V, Ruel MM, Lafontaine E, Chouinard P, Girard F. Impact of pregabalin on the occurrence of postthoracotomy pain syndrome: a randomized trial. Reg Anesth Pain Med. 2015 May-Jun;40(3):262-9. doi: 10.1097/AAP.0000000000000241.</citation>
    <PMID>25899956</PMID>
  </reference>
  <reference>
    <citation>Kranke P, Jokinen J, Pace NL, Schnabel A, Hollmann MW, Hahnenkamp K, Eberhart LH, Poepping DM, Weibel S. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database Syst Rev. 2015 Jul 16;(7):CD009642. doi: 10.1002/14651858.CD009642.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Jun 04;6:CD009642.</citation>
    <PMID>26184397</PMID>
  </reference>
  <reference>
    <citation>Bailey M, Corcoran T, Schug S, Toner A. Perioperative lidocaine infusions for the prevention of chronic postsurgical pain: a systematic review and meta-analysis of efficacy and safety. Pain. 2018 Sep;159(9):1696-1704. doi: 10.1097/j.pain.0000000000001273.</citation>
    <PMID>29757886</PMID>
  </reference>
  <reference>
    <citation>Bunchungmongkol N, Pipanmekaporn T, Paiboonworachat S, Saeteng S, Tantraworasin A. Incidence and risk factors associated with ipsilateral shoulder pain after thoracic surgery. J Cardiothorac Vasc Anesth. 2014 Aug;28(4):979-82. doi: 10.1053/j.jvca.2013.10.008. Epub 2014 Jan 18.</citation>
    <PMID>24447497</PMID>
  </reference>
  <reference>
    <citation>Martinez-Barenys C, Busquets J, de Castro PE, Garcia-Guasch R, Perez J, Fernandez E, Mesa MA, Astudillo J. Randomized double-blind comparison of phrenic nerve infiltration and suprascapular nerve block for ipsilateral shoulder pain after thoracic surgery. Eur J Cardiothorac Surg. 2011 Jul;40(1):106-12. doi: 10.1016/j.ejcts.2010.10.025. Epub 2010 Dec 8.</citation>
    <PMID>21145244</PMID>
  </reference>
  <reference>
    <citation>Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, Chappell A, Chartier K, Cleeland CS, Costello A, Cowan P, Dimitrova R, Ellenberg S, Farrar JT, French JA, Gilron I, Hertz S, Jadad AR, Jay GW, Kalliomäki J, Katz NP, Kerns RD, Manning DC, McDermott MP, McGrath PJ, Narayana A, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Reeve BB, Rhodes T, Sampaio C, Simpson DM, Stauffer JW, Stucki G, Tobias J, White RE, Witter J. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain. 2010 May;149(2):177-93. doi: 10.1016/j.pain.2010.02.018. Epub 2010 Mar 6. Review.</citation>
    <PMID>20207481</PMID>
  </reference>
  <reference>
    <citation>Kendall MC, McCarthy RJ, Panaro S, Goodwin E, Bialek JM, Nader A, De Oliveira GS Jr. The Effect of Intraoperative Systemic Lidocaine on Postoperative Persistent Pain Using Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials Criteria Assessment Following Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial. Pain Pract. 2018 Mar;18(3):350-359. doi: 10.1111/papr.12611. Epub 2017 Sep 13.</citation>
    <PMID>28691269</PMID>
  </reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>September 9, 2018</study_first_submitted>
  <study_first_submitted_qc>September 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2018</study_first_posted>
  <last_update_submitted>November 5, 2018</last_update_submitted>
  <last_update_submitted_qc>November 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangzhou First People's Hospital</investigator_affiliation>
    <investigator_full_name>Xiangcai Ruan, MD, PhD, Vice-Director in Dept Anesth &amp; Pain</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>postthoracotomy pain syndrome</keyword>
  <keyword>chronic pain</keyword>
  <keyword>lidocaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

